what is gemcitabine and nab-paclitaxel?

Q: what is gemcitabine and nab-paclitaxel?

In short Gemcitabine and nab-paclitaxel are two medicines used together to treat advanced or metastatic pancreatic cancer [2]. This combination helps patients live longer and keeps the cancer from growing for a longer time compared to using gemcitabine alone [2]. The details Gemcitabine is a chemotherapy drug that stops cancer cells from growing [1]. Nab-paclitaxel is another medicine that also helps stop cancer growth [2]. When used together, they are given on days 1, 8, and 15 every four weeks [2]. In patients with metastatic pancreatic cancer (cancer that has spread to other parts of the body), this combination improved survival [2]. The median overall survival was 8.5 months for those taking both drugs, compared to 6.7 months for those taking only gemcitabine [2]. It also helped keep the disease from getting worse for longer (median progression-free survival of 5.5 months vs. 3.7 months) and helped shrink tumors more often (response rate of 23% vs. 7%) [2]. What to know Patients taking this combination may experience side effects like low white blood cell counts (neutropenia), tiredness, and nerve damage (neuropathy) [2]. These side effects can be serious, with grade 3 or higher rates being higher than with gemcitabine alone [2]. Recent research suggests that other treatments, such as NALIRIFOX, may work better than gemcitabine and nab-paclitaxel for some patients with metastatic disease [1]. You should talk to your doctor about which treatment is right for you.

Question

Accepted Answer

In short

Gemcitabine and nab-paclitaxel are two medicines used together to treat advanced or metastatic pancreatic cancer [2]. This combination helps patients live longer and keeps the cancer from growing for a longer time compared to using gemcitabine alone [2].

The details

Gemcitabine is a chemotherapy drug that stops cancer cells from growing [1]. Nab-paclitaxel is another medicine that also helps stop cancer growth [2].

When used together, they are given on days 1, 8, and 15 every four weeks [2].

In patients with metastatic pancreatic cancer (cancer that has spread to other parts of the body), this combination improved survival [2]. The median overall survival was 8.5 months for those taking both drugs, compared to 6.7 months for those taking only gemcitabine [2].

It also helped keep the disease from getting worse for longer (median progression-free survival of 5.5 months vs. 3.7 months) and helped shrink tumors more often (response rate of 23% vs. 7%) [2].

What to know

Patients taking this combination may experience side effects like low white blood cell counts (neutropenia), tiredness, and nerve damage (neuropathy) [2]. These side effects can be serious, with grade 3 or higher rates being higher than with gemcitabine alone [2]. Recent research suggests that other treatments, such as NALIRIFOX, may work better than gemcitabine and nab-paclitaxel for some patients with metastatic disease [1]. You should talk to your doctor about which treatment is right for you.